Skip to main content

RHUMBLINE ADVISERS

Position in NEO — Neogenomics Inc

CIK 1115418 BOSTON, MA

Position in NEO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$2,701,035
-$1,500,295 QoQ
Shares Held
364,021
+1.9% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 42% Shared 0% None 58%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,136,235,129 across 32 Diagnostics & Research names. NEO ranks #21 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,701,035 364,021
2025-12-31 $4,201,330 357,256
2025-09-30 $2,954,096 382,655
2025-06-30 $2,839,240 388,405
2025-03-31 $3,478,929 366,589
2024-12-31 $6,410,769 389,003
2024-09-30 $5,603,598 379,905
2024-06-30 $5,303,000 382,336
2024-03-31 $6,062,150 385,633
2023-12-31 $6,228,313 384,939
2023-09-30 $5,047,735 410,385
2023-06-30 $6,582,850 409,636
2023-03-31 $7,283,612 418,358
2022-12-31 $3,749,370 405,776
2022-09-30 $3,238,634 376,148
2022-06-30 $2,928,588 359,336
2022-03-31 $3,670,041 302,061
2021-12-31 $9,637,978 282,473
2021-09-30 $13,187,368 273,370
2021-06-30 $14,141,191 313,066
2021-03-31 $15,150,104 314,122
2020-12-31 $16,202,771 300,943
2020-09-30 $10,746,536 291,313
2020-06-30 $10,052,700 324,490
2020-03-31 $8,863,251 321,016